AstraZeneca's new lab to host key research work

1871 Investors following AstraZeneca. Share this News with them.

0

Like this story, share it with millions of investors on M3

AstraZeneca's new lab to host key research work

AstraZeneca's newly commissioned process R&D laboratory in Bangalore will play a key role in the development of its new drug portfolio, in particular the tuberculosis drug coming out of India, according to its top officials.

Post your opinion here

 

0

Tweet

Share on Tumblr

RELATED NEWS AstraZeneca inaugurates R&D lab in Bangalore AstraZeneca expanding R&D operation in India ALSO READ See latest News about AstraZeneca See previous management interviews See what other Experts & Brokerages are saying about AstraZeneca AstraZeneca BSE | NSE 25/05/12 Are Mutual Funds betting on AstraZeneca?

Bangalore March 22

AstraZeneca 's newly commissioned process R&D laboratory in Bangalore will play a key role in the development of its new drug portfolio, in particular the tuberculosis drug coming out of India, according to its top officials.

The PR&D lab built at $ 15 million was launched by the company CEO, Mr David Brennan, on Wednesday; it is the fourth such for the company and the first outside Europe; two are in the UK and one in Sweden.

It will grow from the current 40 to 75 scientists soon.

Dr Jan Lundberg, Executive Vice-President, Discovery Research, said, "This investment is not the end."

Dr David Haywood, Global Vice-President, Global Process R&D, said the Bangalore group could later develop outsourcing capabilities for large-scale laboratory work in India. According to Dr Sudhir Nambiar, Director of the new lab, it will train pharma-biotech students in process safety.

contd on page 2...